Department of Hepatopancreatobiliary and Transplant Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil.
Department of Surgery, San Lucas Hospital, Rio de Janeiro, Brazil.
Int J Med Robot. 2021 Jun;17(3):e2238. doi: 10.1002/rcs.2238. Epub 2021 Mar 1.
Hepatocellular carcinoma (HCC) is a common indication for associating liver partition with portal vein ligation for staged hepatectomy (ALPPS). Robotic liver resection has been done for HCC, but robotic ALPPS is a rare procedure.
To present three cases of totally robotic ALPPS in cirrhotic patients with HCC.
Three cirrhotic male patients with HCC underwent ALPPS; the mean age was 54.3 years. MELD score was ≤9 and tumour size between 90 and 140 mm. The mean hypertrophy of the future liver remnant after the first stage was 77.5% and no postoperative liver failure was reported. Mean operative time of stage 1 was 7:30 h and of stage 2 was 4:37 h, without blood transfusion. The mean hospital stay for the first stage was 10 days and for the second stage was 9.3 days. No postoperative complication was recorded.
Robotic ALPPS in cirrhotic patients with HCC is safe and feasible.
肝细胞癌（HCC）是联合肝脏分隔和门静脉结扎的分阶段肝切除术（ALPPS）的常见适应证。机器人肝切除术已用于 HCC，但机器人 ALPPS 是一种罕见的手术。
介绍 3 例肝硬化合并 HCC 患者行完全机器人 ALPPS 的情况。
3 例肝硬化合并 HCC 的男性患者接受了 ALPPS；平均年龄为 54.3 岁。MELD 评分≤9 分，肿瘤大小为 90-140mm。第一阶段后未来肝脏残余物的平均增生率为 77.5%，无术后肝功能衰竭报告。第一阶段的平均手术时间为 7:30 小时，第二阶段为 4:37 小时，无需输血。第一阶段的平均住院时间为 10 天，第二阶段为 9.3 天。无术后并发症记录。
机器人辅助肝硬化合并 HCC 的 ALPPS 是安全可行的。
Zotero 插件